SANDOZ PERINDOPRIL ERBUMINE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: ff40e17e7ca15cdc
Drug Approval Canada Name: SANDOZ PERINDOPRIL ERBUMINE
Product Name: SANDOZ PERINDOPRIL ERBUMINE
Status: Marketed
Status Date: 2018-03-05
Original Market Date: 2018-03-05
Din: 02470225
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:32.04
Atc Original: C09AA04 PERINDOPRIL
Atc Name: c 09 aa 04
Aig Number: 0127178001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

PERINDOPRIL ERBUMINE

2 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ff40e17e7ca15cdc

Type

Standard